Transplant

Take control of your CMV testing with artus CMV RGQ MDx.

The artus CMV RGQ MDx workflow is FDA-approved to aid in the management of CMV infection in solid-organ transplant patients. The artus CMV RGQ MDx Kit is optimized for your needs, enabling highly accurate PCR-based viral load testing for human cytomegalovirus (CMV) DNA for small- to medium-throughput laboratories. The workflow offers a rapid turnaround time from sample to result of approximately 3 hours.


The artus CMV RGQ MDx workflow combines the EZ1 DSP Virus Kit and the EZ1 Advanced XL instrument for sample preparation and the Rotor-Gene Q MDx instrument for CMV amplification and quantification. The workflow is ready for implementation, and no further clinical validation is required.

Importantly, the Rotor-Gene Q MDx reports final CMV viral load results in International Units (IU) traceable to the 1^st International WHO Standard, meeting 2016 CAP requirements (1). The artus CMV RGQ MDx Kit targets the highly-conserved MIE gene within the CMV genome, providing quantifiable CMV detection as low as 159 IU/ml and accurate quantification over a broad linear range up to 7.94 x 10⁷ IU/ml.

(1) College of American Pathologists (2015) Viral Load Survey / VLS-C 2015 Kit Instructions